RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:FDA's Head of CBER wants faster approvals with SE/biomarkersfastrrack5 - if you cannot see the relevance of pelareorep receiving orphan drug status in a number if relevant indications that could receive Accelerated Approval under the FDA's Warp Speed program, then you are lost somewhere in the world of the 60's "Get Smart" comedy crowd.